Cocrystal Pharma, Inc.
COCP
Last
$1.08
Day
+0.9%
1y
-12.3%
5y
-91.1%
52w
-47.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
1.13
EMA 50
1.12
EMA 200
1.14
20d high
-16.4%
5y high
-91.3%
5y range
3th
Positions held
Your positionsCOCP isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
10
Hold
watch
Signal
Neutral
Target
$1.19
Stop
$0.97
Stop distance
10.2%
Target vs last
+10.2%
Fundamentals
| Market cap | $20.61M | Enterprise value | $19.78M | Trailing P/E | — | Forward P/E | -1.84 |
| PEG | — | Price / book | 14.08 | Beta | 1.48 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | -30.3% |
| Profit margin | 0.0% | ROE | -3.1% | ROA | -96.1% | Debt / equity | 1.28 |
| Current ratio | 1.24 | Free cash flow | -$4.32M | Analyst recommendation | none | Mean target | $9.00 |
| 52w high | $2.03 | 52w low | $0.76 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.1M | $0.2M | $0.0M | $0.0M | $0.0M | — |
| Op margin | -3032.4% | -1047.1% | — | — | — | — |
| Net income | -$3.2M | -$2.3M | -$2.4M | -$2.0M | -$2.1M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.2M | -$2.4M | -$2.5M | -$2.1M | -$2.1M | — |
- Revenue -53% vs prior quarter ($0.1M vs $0.2M).
- Operating margin compressed to -3032.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$8.8M | -$17.5M | -$18.0M | -$38.8M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$9.0M | -$17.9M | -$21.2M | -$18.1M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-18 · A norovirus breakthrough?; another women’s healthtech haul
2026-09-15 · Cocrystal Pharma’s new CEO hopes to crack the norovirus code
2026-08-31 · Cocrystal Pharma: The Strategic Reset Investors May Be Missing
2026-08-20 · COCP: $5 Million Private Placement with OPKO Health
2026-08-17 · Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
2026-08-03 · Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Price (daily)
Full chart · RSI · MACD · patternsCOCP · daily-10.1% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin